Literature DB >> 18774240

The kinetics of feline leukaemia virus shedding in experimentally infected cats are associated with infection outcome.

Valentino Cattori1, Ravi Tandon, Barbara Riond, Andrea C Pepin, Hans Lutz, Regina Hofmann-Lehmann.   

Abstract

Feline leukaemia virus (FeLV) infection in felids results mainly from oronasal exposure to infectious saliva and nasal secretions, but the potential for viral transmission through faeces and urine has not been completely characterized. In order to assess and compare potential FeLV transmission routes, we determined the viral kinetics in plasma, saliva, faeces and urine during early experimental FeLV infection (up to week 15 post-exposure) in specific pathogen-free cats. In addition to monitoring p27 antigen levels measured by ELISA, we evaluated the presence of infectious particles by cell culture assays and quantified viral RNA loads by a quantitative real-time TaqMan polymerase chain reaction. RNA load was associated with infection outcome (high load-progressive infection; low load-regressive infection) not only in plasma, but also in saliva, faeces and urine. Infectious virus was isolated from the saliva, faeces and urine of infected cats with progressive infection as early as 3-6 weeks post-infection, but usually not in cats with regressive infection. In cats with progressive infection, therefore, not only saliva but also faeces and to some extent urine might represent potential FeLV transmission routes. These results should be taken into account when modelling FeLV-host interactions and assessing FeLV transmission risk. Moreover, during early FeLV infection, detection of viral RNA in saliva may be used as an indicator of recent virus exposure, even in cats without detectable antigenaemia/viraemia. To determine the clinically relevant outcome of FeLV infection in exposed cats, however, p27 antigen levels in the peripheral blood should be measured.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18774240     DOI: 10.1016/j.vetmic.2008.07.001

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  11 in total

1.  Molecular Detection of Feline Leukemia Virus in Oral, Conjunctival, and Rectal Mucosae Provides Results Comparable to Detection in Blood.

Authors:  Raphael Mattoso Victor; Juliana Marques Bicalho; Manuela Bamberg Andrade; Bruna Lopes Bueno; Luiza Rodrigues Alves de Abreu; Adriane Pimenta da Costa Val Bicalho; Jenner Karlisson Pimenta Dos Reis
Journal:  J Clin Microbiol       Date:  2020-01-28       Impact factor: 5.948

2.  Feline Leukemia Virus (FeLV) Disease Outcomes in a Domestic Cat Breeding Colony: Relationship to Endogenous FeLV and Other Chronic Viral Infections.

Authors:  Jordan A Powers; Elliott S Chiu; Simona J Kraberger; Melody Roelke-Parker; Isabella Lowery; Katelyn Erbeck; Ryan Troyer; Scott Carver; Sue VandeWoude
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

3.  Discovery of drugs that possess activity against feline leukemia virus.

Authors:  Willie M Greggs; Christine L Clouser; Steven E Patterson; Louis M Mansky
Journal:  J Gen Virol       Date:  2012-01-18       Impact factor: 3.891

4.  Dominance of highly divergent feline leukemia virus A progeny variants in a cat with recurrent viremia and fatal lymphoma.

Authors:  A Katrin Helfer-Hungerbuehler; Valentino Cattori; Felicitas S Boretti; Pete Ossent; Paula Grest; Manfred Reinacher; Manfred Henrich; Eva Bauer; Kim Bauer-Pham; Eva Niederer; Edgar Holznagel; Hans Lutz; Regina Hofmann-Lehmann
Journal:  Retrovirology       Date:  2010-02-19       Impact factor: 4.602

5.  Broadening the use of antiretroviral therapy: the case for feline leukemia virus.

Authors:  Willie M Greggs; Christine L Clouser; Steven E Patterson; Louis M Mansky
Journal:  Ther Clin Risk Manag       Date:  2011-03-16       Impact factor: 2.423

6.  Retroviral DNA--the silent winner: blood transfusion containing latent feline leukemia provirus causes infection and disease in naïve recipient cats.

Authors:  Stefanie Nesina; A Katrin Helfer-Hungerbuehler; Barbara Riond; Felicitas S Boretti; Barbara Willi; Marina L Meli; Paula Grest; Regina Hofmann-Lehmann
Journal:  Retrovirology       Date:  2015-12-21       Impact factor: 4.602

7.  Diagnostic performances of two rapid tests for detection of feline leukemia virus antigen in sera of experimentally feline leukemia virus-infected cats.

Authors:  Matthew R Krecic; Sridhar Velineni; Patrick Meeus; Huihao Fan; Michael Loenser
Journal:  JFMS Open Rep       Date:  2018-01-02

8.  Prevalence and Genomic Diversity of Feline Leukemia Virus in Privately Owned and Shelter Cats in Aburrá Valley, Colombia.

Authors:  Carolina Ortega; Alida C Valencia; July Duque-Valencia; Julián Ruiz-Saenz
Journal:  Viruses       Date:  2020-04-20       Impact factor: 5.048

9.  Follow-Up of Viral Parameters in FeLV- or FIV-Naturally Infected Cats Treated Orally with Low Doses of Human Interferon Alpha.

Authors:  Esperanza Gomez-Lucia; Victorio M Collado; Guadalupe Miró; Sonsoles Martín; Laura Benítez; Ana Doménech
Journal:  Viruses       Date:  2019-09-11       Impact factor: 5.048

10.  Pan-European Study on the Prevalence of the Feline Leukaemia Virus Infection - Reported by the European Advisory Board on Cat Diseases (ABCD Europe).

Authors:  Nadine Studer; Hans Lutz; Claude Saegerman; Enikö Gönczi; Marina L Meli; Gianluca Boo; Katrin Hartmann; Margaret J Hosie; Karin Moestl; Séverine Tasker; Sándor Belák; Albert Lloret; Corine Boucraut-Baralon; Herman F Egberink; Maria-Grazia Pennisi; Uwe Truyen; Tadeusz Frymus; Etienne Thiry; Fulvio Marsilio; Diane Addie; Manfred Hochleithner; Filip Tkalec; Zsuzsanna Vizi; Anna Brunetti; Boyko Georgiev; Louisa F Ludwig-Begall; Flurin Tschuor; Carmel T Mooney; Catarina Eliasson; Janne Orro; Helle Johansen; Kirsi Juuti; Igor Krampl; Kaspars Kovalenko; Jakov Šengaut; Cristina Sobral; Petra Borska; Simona Kovaříková; Regina Hofmann-Lehmann
Journal:  Viruses       Date:  2019-10-29       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.